Literature DB >> 7577468

Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis.

M Yashiro1, Y S Chung, S Nishimura, T Inoue, M Sowa.   

Abstract

Determination of the differences between cell lines which are derived from a primary tumour and a disseminated metastatic lesion from the same patient may aid in elucidating the factors associated with disseminated metastases. We report on the establishment and characterisation of two new scirrhous gastric cancer cell lines, designated OCUM-2M and OCUM-2D, derived from a 49-year-old female. OCUM-2M was derived from a primary gastric tumour, and OCUM-2D was derived from a sample of disseminated metastasis. The two cell lines were derived from the same patient. We investigated biological differences between the two cell lines to study mechanisms involved in disseminated metastasis. The growth activity of OCUM-2D cells as determined by doubling time and tumorigenicity was greater than that of OCUM-2M cells. The level of epidermal growth factor receptor (EGFR) expression in OCUM-2D cells was about twice that of OCUM-2M cells and the growth of OCUM-2D cells was stimulated more by epidermal growth factor (EGF) than that of OCUM-2M cells. The invasive activity of OCUM-2D cells was higher than that of OCUM-2M cells and was increased after addition of transforming growth factor-beta 1 (TGF-beta 1). An increase in the number of attached and spreading cells was found following the addition of 10 ng ml-1 TGF-beta 1. These findings suggest that high growth and invasive activity may play an important role in disseminated metastasis and that EGF and TGF-beta 1, which affect the growth and invasive activity of OCUM-2D cells, might be factors associated with metastasis in scirrhous gastric carcinoma. The two cell lines OCUM-2M and OCUM-2D should be beneficial for analysing mechanisms of tumour progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577468      PMCID: PMC2033934          DOI: 10.1038/bjc.1995.486

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  33 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

3.  Biphasic effect of cell surface sialic acids on pancreatic cancer cell adhesiveness.

Authors:  T Sawada; J J Ho; T Sagabe; W H Yoon; Y S Chung; M Sowa; Y S Kim
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

4.  Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.

Authors:  K Yanagihara; T Seyama; M Tsumuraya; N Kamada; K Yokoro
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

5.  Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro.

Authors:  D L Mooradian; J B McCarthy; K V Komanduri; L T Furcht
Journal:  J Natl Cancer Inst       Date:  1992-04-01       Impact factor: 13.506

6.  Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium.

Authors:  K Yanagihara; N Kamada; M Tsumuraya; F Amano
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

7.  Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.

Authors:  M Ito; W Yasui; E Kyo; H Yokozaki; H Nakayama; H Ito; E Tahara
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

8.  Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium.

Authors:  A Takada; K Ohmori; T Yoneda; K Tsuyuoka; A Hasegawa; M Kiso; R Kannagi
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

9.  Expression of c-myc gene product in gastric carcinoma.

Authors:  I Ninomiya; Y Yonemura; H Matsumoto; K Sugiyama; T Kamata; K Miwa; I Miyazaki; H Shiku
Journal:  Oncology       Date:  1991       Impact factor: 2.935

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

View more
  33 in total

1.  Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts.

Authors:  Wei-meng Zhao; Lihong Wang; Hangil Park; Sophea Chhim; Melanie Tanphanich; Masakazu Yashiro; K Jin Kim
Journal:  Clin Cancer Res       Date:  2010-07-29       Impact factor: 12.531

2.  Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia.

Authors:  Hiroaki Kasashima; Masakazu Yashiro; Haruhito Kinoshita; Tatsunari Fukuoka; Tamami Morisaki; Go Masuda; Katsunobu Sakurai; Naoshi Kubo; Masaichi Ohira; Kosei Hirakawa
Journal:  Gastric Cancer       Date:  2015-06-23       Impact factor: 7.370

3.  A synergistic antitumor effect of interleukin-2 addition with CD80 immunogene therapy for peritoneal metastasis of gastric carcinoma.

Authors:  Kinshi Kosaka; Masakazu Yashiro; Yoji Sakate; Kosei Hirakawa
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

4.  Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.

Authors:  Isao Oze; Shu Shimada; Hiromi Nagasaki; Yoshimitsu Akiyama; Miki Watanabe; Yasushi Yatabe; Keitaro Matsuo; Yasuhito Yuasa
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-01       Impact factor: 4.553

Review 5.  The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.

Authors:  Masakazu Yashiro; Tasuku Matsuoka; Masaichi Ohira
Journal:  Hum Cell       Date:  2018-06-06       Impact factor: 4.174

6.  Plasminogen activator inhibitor 1 RNAi suppresses gastric cancer metastasis in vivo.

Authors:  Nobuaki Nishioka; Tasuku Matsuoka; Masakazu Yashiro; Kosei Hirakawa; Kenneth Olden; John D Roberts
Journal:  Cancer Sci       Date:  2012-01-09       Impact factor: 6.716

7.  Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?

Authors:  Ali Murat Sedef; Fatih Köse; Ahmet Taner Sümbül; Özlem Doğan; Ali Ayberk Beşen; Ali Murat Tatlı; Hüseyin Mertsoylu; Ahmet Sezer; Sadık Muallaoğlu; Özgür Özyılkan; Hüseyin Abalı
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

8.  Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis.

Authors:  T Fujihara; T Sawada; K Hirakawa; Y S Chung; M Yashiro; T Inoue; M Sowa
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

9.  Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer.

Authors:  T Matsuoka; K Hirakawa; Y S Chung; M Yashiro; S Nishimura; T Sawada; I Saiki; M Sowa
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

10.  Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.

Authors:  Y Kato; M Yashiro; S Noda; M Tendo; S Kashiwagi; Y Doi; T Nishii; J Matsuoka; Y Fuyuhiro; O Shinto; T Sawada; M Ohira; K Hirakawa
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.